Please assess the completion status of the following clinical trial:

Trial Title: Effect of Acetyl-L-carnitine on Chronic Pancreatitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Only patients with chronic pancreatitis are included.~Exclusion Criteria:~* Patients with pancreatic pseudocysts, abscesses, pseudoaneurysms, pancreatitic fistulas, pancreatic adenocarcinoma,~* Females that are pregnant or lactating~* Children are excluded.~* Patients suffering from seizure or thyroid disorders are also excluded due to possible exaggeration of their symptoms from taking ALC according to manufacturer.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Acetyl-L-carnitine 1000mg 2X per day for 3 months

Based on this trial design, predict the completion outcome and termination type (if applicable).